Cellectis Financials - Benzinga

Cellectis SA

CLLSNASDAQ

Trade with Public

Trade with Public

$3.40

-0.065-1.87%

At close: Aug 21, 5:00 PM EST

$3.25

-0.15-4.55%

After Hours: Aug 20, 9:29 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Compare Options Stock Report

Cellectis Financials

Cellectis (CLLS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Cellectis Q2 Adj. EPS $(0.19) Beats $(0.27) Estimate, Sales $6.904M Miss $13.225M Estimate

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.27) by 29.63 percent. This is a 13.64 percent increase over losses of $(0.22) per share from the

Benzinga Newsdesk

PRO
Cellectis Q1 Adj. EPS $(0.16) Beats $(0.27) Estimate, Sales $7.548M Miss $12.267M Estimate

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.27) by 40.74 percent. This is a 5.88 percent increase over losses of $(0.17) per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 11, 2026

Benzinga Insights

Earnings Scheduled For March 19, 2026

Benzinga Insights

PRO
Cellectis Q3 Adj. EPS $0.02 Beats $(0.28) Estimate, Sales $37.164M Beat $6.900M Estimate

Cellectis (NASDAQ:CLLS) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.28) by 107.19 percent. This is a 109.09 percent increase over losses of $(0.22) per share from the

Benzinga Newsdesk

Earnings Scheduled For November 7, 2025

Benzinga Insights